Can we prevent malignant hyperthermia after hypothermic cardiopulmonary bypass in a malignant hyperthermia-susceptible patient?

Anesth Analg. 2007 Jan;104(1):214; author reply 214-5. doi: 10.1213/01.ane.0000249792.37338.cc.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Aged
  • Cardiopulmonary Bypass / adverse effects*
  • Coronary Artery Bypass
  • Disease Susceptibility
  • Humans
  • Hypothermia, Induced
  • Male
  • Malignant Hyperthermia / prevention & control*